National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)

This program funds cooperative research groups working on new treatments and research tools for mental disorders, including drug discovery, biologics, and device development, with support through preclinical work, early human studies, and first-in-human or Phase I trials. It is open to U.S. higher education institutions, nonprofits, for-profits, governments, tribal governments, faith-based and community organizations, regional organizations, foreign organizations, and other listed entities, but non-domestic foreign entities and non-domestic components of U.S. organizations are not eligible to apply. Award budgets are not limited, the project period may not exceed five years, and cost sharing is not required. The number of awards depends on NIH appropriations and the number of meritorious applications. Foreign components are allowed, and academic-industry partnerships are strongly encouraged.

✳ AI-generated summary — verify against the announcement

• Health
• Research & Discovery
• Technology & Product Development
• Patients & People with Health Conditions
• Biomedical & Disease Research
• Mental & Behavioral Health
• Substance Use & Addiction

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments